Business Editors/Health & Medical Writers

    FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--June 7, 2002--Pediatrix Medical Group, Inc. (NYSE:PDX) announced that yesterday, June 6, it received a written request from the Federal Trade Commission to submit information on a voluntary basis in connection with an investigation relating to Pediatrix's May 2001 merger with Magella Healthcare Corporation.
    The request expressly states that the existence of the inquiry "should not be viewed as an accusation by the Federal Trade Commission or its staff of any wrongdoing" on the part of Pediatrix.
    Pediatrix intends to cooperate fully with the Federal Trade Commission, but at this time cannot predict whether the investigation will have a material adverse effect on its business, financial condition or results of operations.

    About Pediatrix

    Pediatrix was founded in 1979. Its neonatal physicians provide services at more than 190 NICUs and through Obstetrix its perinatal physicians provide services in many markets where Pediatrix's neonatal physicians practice. Combined, Pediatrix and its affiliated professional corporations employ more than 600 physicians in 29 states and Puerto Rico. Additional information is available on the Internet: http://www.pediatrix.com.

    Matters discussed in this release may include forward-looking statements within the meaning of the securities laws. All statements, other than statements of historical facts, that address activities, events or developments that Pediatrix intends, expects, believes or anticipates will or may occur in the future are forward-looking statements. These statements are based on assumptions and assessments made by Pediatrix's management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be relevant. Any forward-looking statement is not a guarantee of future performance and is subject to various risks and uncertainties that could cause actual results, developments and business decisions to differ materially from those contemplated by such forward-looking statement. Such risks and uncertainties include, among others: billing and other investigations by government authorities; our ability to comply with laws and regulations applicable to the healthcare industry; limitations of, reductions in or retroactive adjustments to reimbursement amounts or rates by government-sponsored healthcare programs; whether our physicians appropriately record the services they provide; our ability to find suitable acquisition candidates and to successfully integrate our future or recent acquisitions; laws protecting the privacy of patient healthcare information; federal and state healthcare reform or changes in government-sponsored healthcare programs; our ability to successfully recruit and retain qualified physicians; malpractice and other lawsuits; the value of our intangible assets, such as goodwill; our ability to manage our growth; fluctuations in our quarterly results; and competition in the healthcare industry.
    Pediatrix more fully describes these and other risk factors in its Annual Report on Form 10-K for the year ended December 31, 2001, filed with the Securities and Exchange Commission. Any forward-looking statements in this press release are made as of the date hereof based on management's current beliefs and expectations and Pediatrix has no obligation to update and revise any such statements, whether as a result of new developments, information or otherwise.

    --30--jar/mi*

    CONTACT:  Pediatrix Medical Group, Inc., Fort Lauderdale
              Bob Kneeley, 954/384-0175, x-5300 (Investor Relations)
              bob_kneeley@pediatrix.com
                 
    KEYWORD:  FLORIDA 
    INDUSTRY KEYWORD:  MEDICAL 
    SOURCE:  Pediatrix Medical Group, Inc.